MegaRobo Technologies
AI For Science · Robotics · Lab Automation
MegaRobo raises nearly $200M backed by Oman's sovereign wealth fund
November 19, 2026
Raised
$200M
The round signals growing investor bets that AI's next breakthroughs will come from physical experiments, not just software.
- MegaRobo Technologies raised nearly $200 million in a new funding round led by the Oman Investment Authority, Oman's sovereign wealth fund.
- Suzhou-based MegaRobo builds 'AI for Science' infrastructure, pairing AI with robotic lab automation to speed drug discovery and also optimizing production yields for semiconductor and display manufacturers.
- Its proprietary One Intelligence Stack links AI models and agents with lab instruments, robotics and automation in a closed think-design-execute-observe-learn loop.
- The raise brings MegaRobo's total funding to about $600 million, including a nearly $300 million Series C in June 2022 that first pushed its valuation above $1 billion.
- MegaRobo has delivered its infrastructure to more than 500 customers, including pharma firms and research institutions, and reported a $206.3 million order backlog as of June 2025.
- Funds will go toward core R&D and expansion across Europe, North America, the Middle East and Asia, while the company remains in the queue for a Hong Kong IPO after filing in mid-2025.
- MegaRobo competes with established lab-automation incumbents like Tecan and Thermo Fisher, and its custom-project model carries thin margins and heavy cash burn.
- The deal reflects a broader investor shift toward 'physical AI' that moves beyond digital models into robotics-driven scientific experimentation, seen as AI's next major growth frontier.
Lead Investors
Oman Investment Authority